University of Geneva at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
University of Geneva brings 2 presentations to ESGCT 2026 in Hamburg. Its work covers cell therapy for eye disease, with a focus on retinal pigment epithelial cells. One line uses Raman spectroscopy to check the quality of genetically modified retinal cells for age-related macular degeneration, and another builds retinal co-culture models for testing therapies.
| Organization | ESGCT 2026 Attendance |
|---|---|
University of Geneva Geneva, Switzerland | |
Poster Wed Oct 28 1:30pm–3:30pm Raman spectroscopy for quality control of genetically modified retinal pigment epithelial cells to treat age-related macular degeneration Poster Thu Oct 29 2:00pm–4:00pm Comparative evaluation of human retina and iPSC-derived retinal pigment epithelial cell monocultures with co-culture for retinal advanced therapy medicinal product testing |
Instantly find 20 buyers from University of Geneva
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction